Return to homepagePandemic Pact

Stanford School of Medicine

  • Funded by Coalition for Epidemic Preparedness Innovations (CEPI)
  • Total publications:0 publications

Grant number: CEPI-1628

Grant search

Key facts

  • Disease

    Ebola, Marburg virus disease

  • Start & end year

    2025

  • Known Financial Commitments (USD)

    $18,000,000

  • Funder

    Coalition for Epidemic Preparedness Innovations (CEPI)

  • Principal Investigator

    N/A

  • Research Location

    99

  • Lead Research Institution

    Stanford School of Medicine

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Supported by up to $18 million in CEPI investment, researchers at Stanford will design and test new vaccine constructs that could provide all-in-one protection against viruses from the Filovirus family. This includes Zaire Ebolavirus, Marburg and Sudan Ebolavirus as well as new filoviruses that we don’t yet know about that could spill over from animals into humans in the future. The research will use cutting-edge artificial intelligence and a nanoparticle vaccine platform to create a range of vaccine candidates that will be tested in preclinical studies. The most promising vaccine candidate will be advanced to the point where it is ready to rapidly enter Phase I clinical trials should an unknown filovirus outbreak emerge.